For patients with advanced gastric cancer, treatment with chemotherapy after surgery can reduce the risk of cancer related death by 34% over five years compared to surgery alone.
Prof Sung Hoon Noh, a gastric surgeon from Yonsei University College of Medicine, Korea, presented 5-year follow-up from the phase III CLASSIC trial, which added combination chemotherapy to a standard surgical procedure called D2 gastrectomy. The chemotherapy regimen studied in the trial is called XELOX, which is a combination of the drugs capecitabine and oxaliplatin.
CLASSIC was a multinational open-label randomised phase III trial performed in South Korea, China and Taiwan. Patients with stage II
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:282020-08-26 14:41:41Study confirms adding chemotherapy to surgery improves survival in advanced gastric cancer
Millions of people each year have polyps successfully removed during colonoscopies. But when a suspicious polyp is bigger than a marble or in a hard-to-reach location, patients are referred for surgery to remove a portion of their colon
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:282020-08-26 14:41:44New alternative to surgery lets doctors remove suspicious polyps, keep colon intact
Simply sending children with asthma a text message each day asking about their symptoms and providing knowledge about their condition can lead to improved health outcomes.
In a study by the Georgia Institute of Technology, pediatric patients who were asked questions about their symptoms and provided information about asthma via SMS text messages showed improved pulmonary function and a better understanding of their condition within four months, compared to other groups.
‘It appears that text messages acted as an implicit reminder for patients to take their medicine and by the end of the study, the kids were more in tune with their illness,’ said study leader Rosa Arriaga, senior research scientist in the College of Computing
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:282020-08-26 14:41:52A text message a day keeps the asthma attack away
Prothrombin complex concentrates (PCCs) are faster and more effective than fresh frozen plasma at reversing hemorrhage caused by the anti-coagulant warfarin, despite plasma being the most commonly used therapy. A literature review suggests that physicians in the United States should join those around the world in following recommendations of multiple specialty organisations to use PCCs as the first line of defence in this common and life-threatening emergency (
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:282020-08-26 14:41:29How to stop bleeding in the ER caused by warfarin
Tiny silicon crystals caused no health problems in monkeys three months after large doses were injected, marking a step forward in the quest to bring such materials into clinics as biomedical imaging agents, according to a new study.
The findings suggest that the silicon nanocrystals, known as quantum dots, may be a safe tool for diagnostic imaging in humans. The nanocrystals absorb and emit light in the near-infrared part of the spectrum, a quality that makes them ideal for seeing deeper into tissue than traditional fluorescence-based techniques.
‘Quantum dots, or nanocrystals, are very, very promising for biomedical imaging applications, but everyone
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:282020-08-26 14:41:37Tiny, brightly shining silicon crystals could be safe for deep-tissue imaging
The diagnosis of death is not always clear-cut, doctors say.
How easy is it to diagnose death? There needs to be international agreement on when and how death is diagnosed, two leading doctors suggest.
At a European meeting of anaesthetists they said improvements in technology mean the line between life and death is less clear. They called for precise guidelines and more research to prevent the rare occasions when people are pronounced dead but are later found to be alive. The World Health Organisation has begun work to develop a global consensus.
In the majority of cases in hospitals, people are pronounced dead only after doctors have examined their heart, lungs and responsiveness, determining there are no longer any heart and breath sounds and no obvious reaction to the outside world.
But Dr Alex Manara, a consultant anaesthetist at Frenchay Hospital in Bristol, said more than 30 reports in medical literature, describing people who had been determined dead but later found to be alive, had driven scientists to question whether the diagnosis of death can be improved.
At a meeting of the European Society for Anaesthesiology he said that on some occasions doctors do not observe the body for long enough before someone is declared dead.
Dr Manara called for internationally agreed guidelines to ensure doctors observe the body for five minutes, in order not to miss anyone whose heart and lungs spontaneously recover. Many institutions in the US and Australia have adopted two minutes as the minimum observation period, while the UK and Canada recommend five minutes. Germany currently has no guidelines and Italy proposes that physicians wait 20 minutes before declaring death, particularly when organ donation is being considered.
Dr Jerry Nolan, consultant in intensive care at the Royal United Hospital in Bath, who is not involved in the conference, said: ‘In hospitals, where patients are monitored closely, and after the appropriate resuscitation has taken place, waiting five minutes to observe the body is a good idea.
‘There is evidence to show that once you start going beyond five minutes without a circulation or oxygen to the brain you start seeing permanent damage to brain cells.’
At the conference, Ricard Valero, professor of anaesthesia at the University of Barcelona, considered the rarer scenario of patients in intensive care units whose hearts and lungs are kept functioning by machines.
In such scenarios, doctors use the concept of brain death – often conducting neurological tests to monitor any brain activity in the patient.
But the criteria used to establish brain death have slight variations across the globe.
In Canada, for example, one doctor is needed to diagnose brain death; in the UK, two doctors are recommended; and in Spain three doctors are required. The number of neurological tests that have to be performed vary too, as does the time the body is observed before death is declared.
‘These variations in practice just do not seem logical,’ Prof Valero said.
He proposed further research to support a global consensus on the most appropriate criteria to diagnose brain death.
Dr Nolan said: ‘In principle an international guideline on death is a very good idea. It is likely to help in terms of the movement of doctors between countries and, importantly, with public confidence.
‘Italians and Brits are probably built in the same way. It makes sense to have the same criteria for death for both.’
BBC
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:282020-08-26 14:41:46Doctors call for global consensus on diagnosis of death
A team of University of California, Riverside researchers have developed a novel transparent skull implant that literally provides a ‘window to the brain’, which they hope will eventually open new treatment options for patients with life-threatening neurological disorders, such as brain cancer and traumatic brain injury.
The team
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:282020-08-26 14:41:32Creating a ?window to the brain?
A study by researchers at Hospital for Special Surgery has provided the first evidence that the shape of a person
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:282020-08-26 14:41:39Cadaver study may help clinicians identify patients who can skip ACL reconstruction after an ACL tear without ramifications
Alloys like bronze and steel have been transformational for centuries, yielding top-of-the-line machines necessary for industry. As scientists move toward nanotechnology, however, the focus has shifted toward creating alloys at the nanometer scale
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:282020-08-26 14:41:49Nanoscale alloys so bright they could have potential medical applications
An Arthritis Research UK-funded study has cast doubt on the effectiveness of using lateral wedge insoles as a means of relieving pain levels among sufferers of medial knee osteoarthritis.
Medial knee osteoarthritis is the most common type of arthritis affecting the knee joint, affecting the inside of the knee between the femur and the tibia.
The University of Manchester team led by Dr Matthew Parkes assessed the efficacy of lateral wedge treatments – shoes and insoles designed to reduce pressure on the knee – in reducing pain, evaluating data from 12 trials involving almost 900 patients.
According to results published in the Journal of the American Medical Association, while the data showed some connection between the use of these wedges and a reduction in pain levels, the findings were extremely inconsistent and failed to provide any evidence of a clear link.
Moreover, the studies that compared lateral wedge treatments to neutral insoles showed there were no advantages at all associated with the lateral wedge options.
This type of insole fits underneath the sole of the shoe and are thicker on the outside than the inside, thereby tilting the foot inward and transferring the weight of the body to a different part of the foot.
However, the Arthritis Research UK-backed report would appear to suggest that the specific design of the insole itself did not have an impact, with the only studies showing any benefit being the ones in which their performance was compared against patients who were not using insoles at all.
The researchers said: ‘These results suggest that compared with control interventions, lateral wedges are not efficacious for the treatment of knee pain in persons with medial knee osteoarthritis.’
Arthritis Research UK is now funding a new clinical trial that will see the Manchester team investigating whether targeting specific sub-groups of people with medial osteoarthritis who respond biologically to wearing lateral wedge insoles gain benefit. A number of insoles and orthotics which have been designed to potentially lower the loads in the knee joint will be tested.
‘The current way that insoles are prescribed don’t appear to work, but this new trial gives us an opportunity to modify them for particular patients whom we think will respond,’ added the spokesman.
Arthritis Research UK
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png442003wmediahttps://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png3wmedia2020-08-26 14:41:282020-08-26 14:41:34Lateral wedge insoles ‘do not help to relieve osteoarthritis pain’
We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.
Google Analytics Cookies
These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
Other external services
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.
Privacy Beleid
U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.